Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

Exclusion Criteria

• •1. Participants assigned to epoetin alfa in a previous ongoing roxadustat anemia study
• •2. Pregnant or breastfeeding females
• •3. Females of childbearing potential, unless using adequate contraception; male participants with sexual partners of childbearing potential who are not on birth control unless the male participant agrees to use adequate contraception
• •4. Participants who received roxadustat in a previous study that did not demonstrate adequate hemoglobin response per the investigator's clinical judgment
• •5. Any medical condition that in the opinion of the investigator may pose a safety risk to a participant in this study or which may interfere with study participation